Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EBS

Emergent BioSolutions

$63.55

-1.59 (-2.44%)

16:28
02/21/19
02/21
16:28
02/21/19
16:28
Earnings
Emergent BioSolutions reports Q4 EPS 75c, consensus 62c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

Over a month ago
EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

, AMPH

Amphastar

$21.90

0.1 (0.46%)

11:57
01/17/19
01/17
11:57
01/17/19
11:57
Recommendations
Emergent BioSolutions, Amphastar analyst commentary at Wells Fargo »

Wells says naloxone news…

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

AMPH

Amphastar

$21.90

0.1 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

, AMPH

Amphastar

$21.91

0.11 (0.50%)

11:55
01/17/19
01/17
11:55
01/17/19
11:55
Hot Stocks
FDA commissioner describes efforts to support development of OTC naloxone »

FDA Commissioner Scott…

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

AMPH

Amphastar

$21.91

0.11 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$58.79

1.28 (2.23%)

06:39
01/07/19
01/07
06:39
01/07/19
06:39
Earnings
Breaking Earnings news story on Emergent BioSolutions »

Emergent BioSolutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

EBS

Emergent BioSolutions

$58.79

1.28 (2.23%)

06:38
01/07/19
01/07
06:38
01/07/19
06:38
Earnings
Emergent BioSolutions sees FY19 revenue $1.06B-$1.14B, consensus $1.02B »

FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

EBS

Emergent BioSolutions

$58.79

1.28 (2.23%)

06:37
01/07/19
01/07
06:37
01/07/19
06:37
Earnings
Emergent BioSolutions narrows FY18 revenue to $779M-$784M, consensus $778.95M »

Prior view was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

EBS

Emergent BioSolutions

$57.51

-0.21 (-0.36%)

07:06
01/04/19
01/04
07:06
01/04/19
07:06
Hot Stocks
Emergent BioSolutions CEO Daniel Abdun-Nabi to retire, Robert Kramer to succeed »

Emergent BioSolutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$58.37

-0.42 (-0.71%)

09:10
12/28/18
12/28
09:10
12/28/18
09:10
Hot Stocks
Emergent BioSolutions submits FDA application for emergency use of NuThrax »

Emergent BioSolutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$60.88

-0.22 (-0.36%)

16:13
12/17/18
12/17
16:13
12/17/18
16:13
Hot Stocks
Emergent BioSolutions receives Health Canada approval for anthrax vaccine NDS »

Emergent BioSolutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

EBS

Emergent BioSolutions

$61.10

-1.04 (-1.67%)

, INSY

Insys Therapeutics

$4.92

0.01 (0.20%)

08:24
12/17/18
12/17
08:24
12/17/18
08:24
Conference/Events
FDA to hold a joint committee meeting »

The Anesthetic &…

EBS

Emergent BioSolutions

$61.10

-1.04 (-1.67%)

INSY

Insys Therapeutics

$4.92

0.01 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.